| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/21/2001 | CN1287852A Hemorrhoidal pastille |
| 03/21/2001 | CN1287849A Traditional Chinese medicine for expelling wind and removing dampness |
| 03/21/2001 | CN1287845A Chrysanthemum flower health-care tea and its prepn. method |
| 03/21/2001 | CN1287804A Nutrient powder food with health-care function for heart and brain |
| 03/21/2001 | CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof |
| 03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/21/2001 | CN1063335C Chinese medicine preparation for reducing fat and dilating coronary artery |
| 03/20/2001 | US6204393 In aqueous solution; controlling ph; neutralization |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204295 Halogenated triphenylethylene derivatives,protection of human organs, from oxidative damage induced by lipid peroxidation and inhibiting the production of reactive oxygen species by activated neutrophils |
| 03/20/2001 | US6204292 Bicyclic metabotropic glutamate receptor ligands |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/20/2001 | US6204280 Oxazolidinone derivative, anticoagulant |
| 03/20/2001 | US6204278 Anilide compounds, including use thereof in ACAT inhibitition |
| 03/20/2001 | US6204268 Cyclic diaza compounds |
| 03/20/2001 | US6203785 Poly(diallylamine)-based bile acid sequestrants |
| 03/20/2001 | CA2132841C Aminocyclohexylamides for antiarrhythmic and anaesthetic uses |
| 03/20/2001 | CA2070169C Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof |
| 03/20/2001 | CA1341206C Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018048A2 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018006A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001018004A2 PYRAZOLO[4,3-d]PYRIMIDINES |
| 03/15/2001 | WO2001018001A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001017999A2 Amino-triazolopyridine derivatives |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017994A1 Oxazole ppar antagonists |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017976A1 Bis-sulfonamides |
| 03/15/2001 | WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 03/15/2001 | WO2001017959A2 Vitronectin receptor antagonists |
| 03/15/2001 | WO2001017957A1 Prostaglandin e analogues |
| 03/15/2001 | WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 03/15/2001 | WO2001017942A1 Amides as inhibitors for pyruvate dehydrogenase |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017596A1 Method of treating cardio pulmonary diseases with no group compounds |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017525A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 03/15/2001 | WO2001017508A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2000078779A3 N-pyrazole a2a receptor agonists |
| 03/15/2001 | WO2000071102A3 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis |
| 03/15/2001 | WO2000061609A3 Prodrugs of thrombin inhibitors |
| 03/15/2001 | WO2000061604A3 Pharmaceutical compounds |
| 03/15/2001 | DE19943815A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
| 03/15/2001 | DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/15/2001 | DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 03/15/2001 | DE19943317C1 Kunststofffolien, insbesondere für die Verwendung in einem dermalen oder transdermalen therapeutischen System und Verfahren zu ihrer Herstellung Plastic films, in particular for use in a dermal or transdermal therapeutic system and method for their preparation |
| 03/15/2001 | DE19942474A1 Pyrazolo[4,3-d]pyrimidine Pyrazolo [4,3-d] pyrimidines |
| 03/15/2001 | DE19941559A1 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie Using Bissulfonamiden for the preparation of medicaments for the prophylaxis or treatment of Hyperlipidömie |
| 03/15/2001 | DE19940944A1 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 03/15/2001 | DE19939044A1 Verwendung von Morphinanderivaten als Arzneimittel Use of morphinan derivatives as medicaments |
| 03/15/2001 | DE19937304A1 Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen Use of CGRP antagonists and CGRP release inhibitors to combat menopausal hot flashes |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384671A1 Vitronectin receptor antagonists |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384151A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | CA2384148A1 Prostaglandin e analogues |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384051A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2383998A1 Amino-triazolopyridine derivatives |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383321A1 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | CA2380763A1 Aminoalkoxy carbazoles for the treatment of cns diseases |
| 03/14/2001 | EP1083231A1 Smooth muscle cell promoter and uses thereof |
| 03/14/2001 | EP1083172A1 N-substituted derivatives of 5-oxyiminobarbituric acid |
| 03/14/2001 | EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B |
| 03/14/2001 | EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082324A1 Imidazopyridine thrombin inhibitors |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082319A1 Benzocarbazol and indenoinole derived estrogenic agents |
| 03/14/2001 | EP1082315A1 Potassium channel inhibitors |
| 03/14/2001 | EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |